IRIS UniCatt

Tortora, Giampaolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.828
EU - Europa 3.084
AS - Asia 1.715
SA - Sud America 262
AF - Africa 70
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.775
IT - Italia 805
SE - Svezia 789
SG - Singapore 725
DE - Germania 331
CN - Cina 318
IN - India 304
BR - Brasile 239
FR - Francia 224
IE - Irlanda 222
ID - Indonesia 153
PL - Polonia 146
GB - Regno Unito 111
FI - Finlandia 99
RU - Federazione Russa 90
AT - Austria 50
NL - Olanda 47
HK - Hong Kong 43
CA - Canada 42
CI - Costa d'Avorio 41
TR - Turchia 32
IR - Iran 27
BE - Belgio 26
CZ - Repubblica Ceca 25
ES - Italia 22
UA - Ucraina 22
AU - Australia 18
CH - Svizzera 18
PK - Pakistan 18
VN - Vietnam 16
JP - Giappone 10
GR - Grecia 8
IL - Israele 7
LT - Lituania 7
LV - Lettonia 7
RO - Romania 7
BD - Bangladesh 6
EC - Ecuador 6
MX - Messico 6
NZ - Nuova Zelanda 6
TW - Taiwan 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
AR - Argentina 5
CO - Colombia 5
EG - Egitto 5
KR - Corea 5
LU - Lussemburgo 5
MA - Marocco 5
PH - Filippine 5
AZ - Azerbaigian 4
CY - Cipro 4
HU - Ungheria 4
IQ - Iraq 4
KE - Kenya 4
SA - Arabia Saudita 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
HR - Croazia 3
KZ - Kazakistan 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
NG - Nigeria 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
VE - Venezuela 2
CD - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
Totale 8.985
Salva come PNG Salva come JPEG
Città #
Ashburn 863
Chandler 684
Singapore 478
Hyderabad 227
Rome 223
Dublin 216
Fairfield 166
Jakarta 147
Warsaw 145
New York 125
Milan 119
The Dalles 112
Princeton 98
Wilmington 98
Helsinki 83
Boston 75
San Mateo 72
Seattle 67
Houston 66
Beijing 65
Moscow 62
Frankfurt am Main 61
Woodbridge 59
Los Angeles 55
Marseille 55
Cambridge 53
Nuremberg 46
Cattolica 44
Chicago 44
Boardman 42
Düsseldorf 42
Abidjan 41
Ann Arbor 40
Hong Kong 40
Munich 37
London 36
Bremen 32
Vienna 31
North Bergen 30
Lauterbourg 27
Brussels 24
Matera 24
Toronto 24
Nanjing 22
Dearborn 21
Falkenstein 20
Brno 19
Portsmouth 18
Redwood City 18
Washington 18
Augusta 17
Council Bluffs 15
Kish 15
Naples 15
Paris 15
Redmond 14
Lappeenranta 13
Norwalk 13
San Diego 13
São Paulo 13
Nanchang 12
Amsterdam 11
Andover 11
Dong Ket 11
Ottawa 11
Pune 11
Belo Horizonte 10
Florence 10
Hangzhou 10
Istanbul 10
Piacenza 10
Zurich 10
Busto Arsizio 9
Shanghai 9
Bari 8
Hebei 8
Karachi 8
Santa Clara 8
Goiânia 7
Leawood 7
Potenza 7
Riga 7
Tokyo 7
Verona 7
Auckland 6
Chennai 6
Curitiba 6
Guangzhou 6
Izmir 6
Madrid 6
Rio de Janeiro 6
Sacramento 6
Tashkent 6
Bologna 5
Edinburgh 5
Gandhinagar 5
Mountain View 5
Newark 5
Prague 5
Sydney 5
Totale 5.665
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 521
Pembrolizumab as first-line treatment for metastatic uveal melanoma 279
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 214
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 206
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 169
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 160
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 135
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 131
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 124
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment 114
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 108
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 105
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 101
Gut microbiome, big data and machine learning to promote precision medicine for cancer 100
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 96
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 90
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 89
Management of single pulmonary metastases from colorectal cancer: State of the art 88
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 87
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 85
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 83
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 82
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 81
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 78
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 78
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 76
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 75
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 75
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 74
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 74
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 73
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 72
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 71
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 71
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 71
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 70
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 68
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 67
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 67
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 67
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 67
Skin cancer triage and management during COVID-19 pandemic. 66
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 66
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 66
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 66
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 65
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 65
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 65
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 65
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 64
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 64
Exploring the molecular and biological background of lung neuroendocrine tumours 63
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 62
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 62
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 61
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 61
Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new? 60
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 60
Efficacy of immune checkpoint inhibitors in different types of melanoma 59
Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview 59
Biomarkers of response to advanced prostate cancer therapy 59
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 58
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 57
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 57
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 57
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 57
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 56
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 56
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 55
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 55
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 54
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response 54
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 53
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 53
Nutritional Support in Lung Cancer Patients: The State of the Art 53
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 52
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis 52
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 51
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 51
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients 50
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 49
The effect of a treatment delay on outcome in metastatic renal cell carcinoma 49
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma 48
Whole-genome landscape of pancreatic neuroendocrine tumours 48
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 47
Molecular alterations in basal cell carcinoma subtypes 47
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 47
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 45
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 45
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 43
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 43
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer 43
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 42
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 40
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 40
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents 39
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 39
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 39
PTEN in colorectal cancer: Shedding light on its role as predictor and target 39
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 39
Totale 7.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 0 0 0 0 0 0 135 25
2020/2021475 25 26 42 37 85 15 32 4 49 51 78 31
2021/20221.024 118 40 25 108 42 38 18 130 49 35 215 206
2022/20232.262 316 285 162 311 127 249 139 164 224 82 99 104
2023/20242.101 59 312 81 88 85 201 364 321 45 82 183 280
2024/20252.808 96 84 313 158 272 152 266 152 564 651 100 0
Totale 9.264